Lifecore Biomedical 's CCO Mark DaFonseca was included in a roundtable featuring Pharma's Almanac.

Public source

Publisher name

Public post

Thanks to Pharma's Almanac for including Lifecore's CCO Mark DaFonseca in this roundtable.

Log in to read the full post

Company

Lifecore Biomedical

End-to-End Sterile Injectables CDMO

Industry
Pharmaceutical Manufacturing
Location
Chaska, US
Company size
201–500 employees

About Lifecore Biomedical

Unsure your filling needs will be fulfilled? Have a complex injectable product or process? We say, "Bring it." Lifecore is a U.S.-based Contract Development and Manufacturing Organization specializing in the development, fill/finish, and commercialization of sterile injectable drugs, biologics, medical devices, and combination products. With a 40+ year regulatory track record and 20+ commercial products, Lifecore offers end-to-end services with experience spanning straightforward to complex formulations, including expertise with highly viscous products (exceeding 100,000 cP). We support organizations of all sizes across pre-clinical, clinical, and commercial stages. Lifecore is also a leading producer of pharmaceutical-grade, non-animal-sourced sodium hyaluronate which is used as an API and excipient. Why choose Lifecore? We’re creative problem solvers who enjoy helping our customers find solutions to complex product and processes. We don’t have limitations on what we’re willing to consider. We’re flexible when onboarding customer processes, methods, and equipment at our facilities. Lifecore Injectables CDMO is our brand name for services provided by our legal entity, Lifecore Biomedical, LLC (or its affilliates).

See more

Latest activity

4 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.